ME00485B - VAKCINE l METODE LIJEČENJA INFLUENCE KOD CANINA - Google Patents

VAKCINE l METODE LIJEČENJA INFLUENCE KOD CANINA

Info

Publication number
ME00485B
ME00485B MEP-2008-765A MEP76508A ME00485B ME 00485 B ME00485 B ME 00485B ME P76508 A MEP76508 A ME P76508A ME 00485 B ME00485 B ME 00485B
Authority
ME
Montenegro
Prior art keywords
influenza
viruses
vaccines
relates
methods
Prior art date
Application number
MEP-2008-765A
Other languages
English (en)
Inventor
Shelly Lynn Shields
Hans Anthony Draayer
Michael John Huether
Original Assignee
Zoetis Services Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc
Publication of ME00485B publication Critical patent/ME00485B/me

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/828—Bacterial vaccine for canidae or mustelidae, e.g. dogs, foxes, minks

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Predmetni pronalazak odnosi se na dobijanje novih vakcina i liječenje bolesti povezanih sacanine influenca virusom. On obuhvata influenca viralne antigene, i metod prenosa ovihantigena caninima, posebno psima. Odnosi se na oslabljene i ubijene vakcine. Ovajpronalazak odnosi se na eksperimentalno generisane canine i equine influenca viruse.Pronalazak takođe obuhvata influenca A, uključujući H3,N8, H3N8, H7N7 i viruse kojisadrže najmanje jedan genomski fragment iz canina ili eguina influenca virusa. Ovajpronalazak se takođe odnosi na upotrebu ovih virusa u terapeutskim jedinjenjima kako bise zaštitili, a posebno psi, od bolesti izazvanih influenca virusima.
MEP-2008-765A 2005-10-07 2006-09-25 VAKCINE l METODE LIJEČENJA INFLUENCE KOD CANINA ME00485B (me)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72482705P 2005-10-07 2005-10-07
PCT/IB2006/002741 WO2007042884A1 (en) 2005-10-07 2006-09-25 Vaccines and methods to treat canine influenza

Publications (1)

Publication Number Publication Date
ME00485B true ME00485B (me) 2011-10-10

Family

ID=37684915

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2008-765A ME00485B (me) 2005-10-07 2006-09-25 VAKCINE l METODE LIJEČENJA INFLUENCE KOD CANINA

Country Status (17)

Country Link
US (2) US7722884B2 (me)
EP (2) EP1945254A1 (me)
JP (2) JP4667507B2 (me)
KR (2) KR20110126726A (me)
CN (1) CN101309701A (me)
AR (1) AR056566A1 (me)
AU (1) AU2006300927B2 (me)
BR (1) BRPI0616328A2 (me)
CA (1) CA2621320C (me)
ME (1) ME00485B (me)
NO (1) NO20082003L (me)
NZ (1) NZ566490A (me)
RS (1) RS20080138A (me)
RU (1) RU2396976C2 (me)
TW (1) TW200730188A (me)
WO (1) WO2007042884A1 (me)
ZA (1) ZA200802892B (me)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11865172B2 (en) 2005-04-21 2024-01-09 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
WO2006116082A1 (en) * 2005-04-21 2006-11-02 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US7959929B2 (en) 2005-04-21 2011-06-14 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US7468187B2 (en) * 2005-10-18 2008-12-23 Iowa State University Research Foundation, Inc. Canine influenza virus and related compositions and methods of use
EP1941033A2 (en) * 2005-10-20 2008-07-09 Wyeth a Corporation of the State of Delaware Compositions and methods for the treatment of canine influenza virus disease
US7682619B2 (en) * 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
US7674469B2 (en) * 2006-10-25 2010-03-09 Internet International B.V. Feline influenza vaccine and method of use
BRPI0720667A8 (pt) * 2006-12-27 2017-04-25 Pfizer Prod Inc Métodos de administração de vacina
GB0705245D0 (en) * 2007-03-19 2007-04-25 Stabilitech Ltd Stable biological products
US20110027308A1 (en) * 2007-09-10 2011-02-03 Intervet International B.V. Compositions and methods for preventing influenza infection in canines, felines and equines
KR100850545B1 (ko) * 2007-10-30 2008-08-05 주식회사 에니멀제네틱스 신규한 개 인플루엔자 바이러스 및 이의 백신
RU2510280C2 (ru) * 2008-06-27 2014-03-27 Пфайзер Инк. Новые адъювантные композиции
US20110110975A1 (en) * 2009-11-06 2011-05-12 Streck, Inc. Inactivated virus compositions and methods of preparing such compositions
AU2011224507A1 (en) * 2010-03-10 2012-08-30 Intervet International B.V. Method for protecting against disease caused by secondary pathogens
CN101892200B (zh) * 2010-03-18 2012-05-30 中国农业科学院哈尔滨兽医研究所 抗h3n8亚型马流感病毒单克隆抗体及其用途
CA3219727A1 (en) * 2010-12-22 2012-06-28 Intervet International B.V. Vaccines comprising live aro mutant bordetella bronchiseptica
CN103596588B (zh) * 2011-02-04 2016-02-03 佐蒂斯有限责任公司 用于犬呼吸道疾病综合征的组合物
PT2670432T (pt) * 2011-02-04 2021-05-04 Zoetis Services Llc Composições imunogénicas de bordetella bronchiseptica
CA3018230A1 (en) 2011-03-14 2012-09-20 Boehringer Ingelheim Vetmedica, Inc. Equine rhinitis b vaccine
US9956281B2 (en) 2011-05-04 2018-05-01 Streck, Inc. Inactivated virus compositions and methods of preparing such compositions
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
US9347065B2 (en) 2012-03-29 2016-05-24 International Aids Vaccine Initiative Methods to improve vector expression and genetic stability
US10555998B2 (en) 2014-11-24 2020-02-11 Intervet Inc. Inactivated equine influenza virus vaccines
WO2017031408A1 (en) * 2015-08-20 2017-02-23 University Of Rochester Single-cycle virus for the development of canine influenza vaccines
US10973903B2 (en) 2015-08-20 2021-04-13 University Of Rochester NS1 truncated virus for the development of canine influenza vaccines
US10478489B2 (en) 2015-08-20 2019-11-19 University Of Rochester Live-attenuated vaccine having mutations in viral polymerase for the treatment and prevention of canine influenza virus
CN105999257A (zh) * 2016-05-11 2016-10-12 长春海基亚生物技术股份有限公司 无针注射流感疫苗系统与应用
US10857224B2 (en) 2016-06-03 2020-12-08 University Of Rochester Equine influenza virus live attenuated vaccines
AR114410A1 (es) 2018-02-27 2020-09-02 Univ Rochester Vacuna multivalente contra influenza viva atenuada para prevenir y controlar el virus influenza equino (vie) en caballos

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8205892D0 (sv) 1982-10-18 1982-10-18 Bror Morein Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
SE8405493D0 (sv) 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
ATE71303T1 (de) 1986-01-14 1992-01-15 Nederlanden Staat Verfahren zur herstellung immunologischer komplexe und diese enthaltende pharmazeutische zusammensetzung.
DE69838992T2 (de) * 1997-09-05 2008-12-24 Glaxosmithkline Biologicals S.A., Rixensart Öl-in-Wasser Emulsionen mit Saponinen
US6051239A (en) 1997-10-20 2000-04-18 Thomas Jefferson University Compositions and methods for systemic delivery of oral vaccines and therapeutic agents
US6177082B1 (en) * 1998-08-13 2001-01-23 The University Of Pittsburgh-Of The Commonwealth System Of Higher Education Cold-adapted equine influenza viruses
US6482414B1 (en) * 1998-08-13 2002-11-19 The University Of Pittsburgh-Of The Commonwealth System Of Higher Education Cold-adapted equine influenza viruses
GB0217434D0 (en) 2002-07-27 2002-09-04 Royal Vetinary College Biological material
US7629440B2 (en) * 2002-08-20 2009-12-08 Genitrix, Llc Lectin compositions and methods for modulating an immune response to an antigen
US20050089533A1 (en) * 2003-01-29 2005-04-28 Joseph Frantz Canine vaccines against Bordetella bronchiseptica
US7572620B2 (en) * 2005-01-11 2009-08-11 Wisconsin Alumni Research Foundation H3 equine influenza A virus
US8137676B2 (en) 2005-02-15 2012-03-20 Mount Sinai School Of Medicine Genetically engineered equine influenza virus and uses thereof
BRPI0609362A2 (pt) * 2005-04-11 2010-03-30 Us Gov Health & Human Serv vetor de adenovìrus recombinante, adenovìrus recombinante, composição imunogênica e método para a produção da referida composição imunogênica
WO2006116082A1 (en) * 2005-04-21 2006-11-02 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
EP1912668A2 (en) * 2005-07-20 2008-04-23 ZymoGenetics, Inc. Il28 and il29 truncated cysteine mutants and antiviral methods of using same
GB0517293D0 (en) 2005-08-24 2005-10-05 Cancer Rec Tech Ltd Vectors and uses thereof
US7384642B2 (en) * 2005-08-25 2008-06-10 Merial Limited Canine influenza vaccines
US7425336B2 (en) 2005-08-25 2008-09-16 Mevial Limited Canine influenza vaccines
US7468187B2 (en) 2005-10-18 2008-12-23 Iowa State University Research Foundation, Inc. Canine influenza virus and related compositions and methods of use
EP1941033A2 (en) * 2005-10-20 2008-07-09 Wyeth a Corporation of the State of Delaware Compositions and methods for the treatment of canine influenza virus disease

Also Published As

Publication number Publication date
ZA200802892B (en) 2009-01-28
JP2009511464A (ja) 2009-03-19
US20080254063A1 (en) 2008-10-16
EP1945254A1 (en) 2008-07-23
CN101309701A (zh) 2008-11-19
RU2396976C2 (ru) 2010-08-20
WO2007042884A1 (en) 2007-04-19
US7722884B2 (en) 2010-05-25
NZ566490A (en) 2011-06-30
TW200730188A (en) 2007-08-16
CA2621320A1 (en) 2007-04-19
BRPI0616328A2 (pt) 2011-06-14
AR056566A1 (es) 2007-10-10
JP4667507B2 (ja) 2011-04-13
JP2009298802A (ja) 2009-12-24
KR20110126726A (ko) 2011-11-23
CA2621320C (en) 2016-05-24
RU2008113207A (ru) 2009-10-10
KR20080042174A (ko) 2008-05-14
AU2006300927A1 (en) 2007-04-19
RS20080138A (en) 2009-07-15
US20070082012A1 (en) 2007-04-12
WO2007042884A9 (en) 2008-05-29
NO20082003L (no) 2008-06-24
EP2452693A2 (en) 2012-05-16
US7879336B2 (en) 2011-02-01
AU2006300927B2 (en) 2010-05-13
EP2452693A3 (en) 2012-06-06

Similar Documents

Publication Publication Date Title
ME00485B (me) VAKCINE l METODE LIJEČENJA INFLUENCE KOD CANINA
CY1120015T1 (el) Μεθοδοι χορηγησης εμβολιων
ATE461710T1 (de) Nipah-virus-impfstoffe
ATE554789T1 (de) Neues hundeinfluenza-virus und imfpstoff hierfür
NZ627888A (en) Materials and methods for respiratory disease control in canines
MY141003A (en) Materials and methods for treating viral infections with a cysteamine compound
DK1105497T3 (da) Koldadapterede hesteinfluenzavira
DK1796717T3 (da) Kombinationsvaccine
WO2007118206A3 (en) Canine influenza virus
ATE408696T1 (de) Peptide aus dem g-protein des respiratorischen synzytialvirus und deren verwendung in einem impfstoff
AR056712A1 (es) Composicion y vacuna efectiva para tratar prevenir o mejorar la inoculacion del virus de la influenza canina metodo pra generar un inmunogen del virus dela influenza equina o del virus de la influenza canina modelo de la inoculacion util para determinar la eficacia de la composicion contra el virus
MX2014009950A (es) Compuestos para tratar la infeccion por parvovirus.
EA200601361A1 (ru) Индукторы монопараиммунитета, основанные на ослабленных вирусах миксомы кролика
WO2011045573A3 (en) Staphylococcal antigens
MX2010002729A (es) Composiciones y metodos para prevenir infeccion de influenza en caninos, felinos y equinos.
HUP0402548A2 (hu) Madárembrió-részecskékből álló biomassza vírusantigének előállítására
ATE431555T1 (de) Verfahren und mittel zur bestimmung der replikationsgeschwindigkeit einer viruspopulation
WO2008070332A3 (en) Feline influenza vaccine and method of use
DE60238554D1 (de) Vakzine gegen infektionskrankheiten
ECSP21039816A (es) Anticuerpos monoclonales antirrábicos y cóctel de estos
RU2020100038A (ru) Материалы и методы, используемые для лечения респираторных заболеваний у собак
DE602006018985D1 (de) Zusammensetzung mit einem kolloidalen synthetischen bioresorbierbaren vektor und einem viralen vektor
ATE553770T1 (de) Masernvirus-nucleoprotein zur behandlung von atherosklerose
SG159529A1 (en) Vaccine
AR099311A1 (es) Métodos de tratamiento de enfermedad de alzheimer